Skip to main content
Log in

Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity

  • Published:
Medical Microbiology and Immunology Aims and scope Submit manuscript

Abstract

A forerunning study on the relationship between antibodies to the protective antigen (PA) and lethal factor (LF) components of anthrax toxin and protective immunity has been expanded and extended to include the third toxin component, the edema factor (EF). It was found that protection against the “vaccine resistant” Ames strain was possible in the absence of detectable anti-LF and anti-EF antibodies. Evidence is given that PA may be the essential anthrax-derived antigen for protection, but that equally essential is that it be presented to the host's immune system in such a manner as to provide stimulation of more than just production of antibody to PA. Titers to the three components in sera of individuals with histories of clinically diagnosed anthrax as well as from human vaccinees are included in the report.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ivins BE, Ezzell JW, Jemski J, Hedlund KW, Ristroph JD, Leppla SH (1986) Immunization studies with attenuated strains of Bacillus anthracis. Infect Immun 52:454–458

    Google Scholar 

  2. Ivins BE, Welkos SL (1986) Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis. Infect Immun 54:537–542

    Google Scholar 

  3. Leppla SH (1982) Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations in eukaryotic cells. Proc Natl Acad Sci USA 79:3162–3166

    Google Scholar 

  4. Leppla SH (1984) Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eukaryotic cells. Adv Cyclic Nucleotide Protein Phosphorylation Res 17:189–198

    Google Scholar 

  5. Quinn CP, Shone CC, Turnbull PCB, Melling J (1988) Purification of anthrax toxin components by high performance anion exchange, gel-filtration and hydrophobic interaction chromatography. Biochem J 252:753–758

    Google Scholar 

  6. Turnbull PCB (1986) Bacillus cereus toxins. In: Dorner F, Drews J (eds) Pharmacology of bacterial toxins. International Encyclopedia of Pharmacology and Therapeutics, Section 119. Permagon Press, Oxford New York, pp 397–448

    Google Scholar 

  7. Turnbull PCB, Broster MG, Carman JA, Manchee RJ, Melling J (1986) Development of anti-bodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Infect Immun 52:356–363

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Turnbull, P.C.B., Leppla, S.H., Broster, M.G. et al. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Med Microbiol Immunol 177, 293–303 (1988). https://doi.org/10.1007/BF00189414

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00189414

Keywords

Navigation